Diabetes Mellitus, Type 2 Clinical Trial
Official title:
The Effect of Resistance Exercise on Postprandial Hyperglycemia in Patients With B-thalassemia Exhibiting Resistance to Insulin (Type II Diabetes and Prediabetes)
It is known that postprandial hyperglycemia increases the cardiometabolic risk in both diabetic and non-diabetic patients. Moreover, there is insufficient data on the effectiveness of exercise on preventing Type II diabetes mellitus in individuals with insulin resistance and prediabetes. This study aims to examine the effectiveness of resistance exercise in limiting postprandial hyperglycemia and the necessity of prescribing medication particularly in patients with beta-thalassemia and insulin resistance.
Type II diabetes mellitus is a condition characterized by chronic hyperglycemia due to
insufficient insulin production and action and tissue resistance to insulin. Pre-diabetes is
also characterized by elevated levels of blood glucose, but not so high as those in diabetes.
Existing studies have shown that postprandial hyperglycemia is associated with an increased
risk for complications of diabetes, both microvascular and macrovascular, as it contributes
to the deficiency of β-pancreatic cells and endothelial dysfunction to a much greater extent
than glycosylated hemoglobin (HbA1c) and fasting glucose.
The main problem in glycemic control is the glucose peak 1-2 hours after the meal. Therefore,
there is a need to investigate whether postprandial exercise can help solve this problem.
Βeta-thalassemia is a group of heterogeneous hereditary anemias characterized by decreased or
no production of beta-chain hemoglobin, resulting in inefficient erythropoiesis. The three
main phenotypes are: a) major b) intermediate and c) heterozygous beta-thalassemia. Major
thalassemia occurs in the first 2 years of life with severe anemia and requires systemic
transfusions. The intermediate appears later and usually does not need transfusions. The
heterozygote is asymptomatic, but some carriers may experience mild anemia. Beta-thalassemia
is inherited in an autosomal recessive manner. Patient survival has increased significantly
in recent years due to systemic transfusions and early treatment of disease complications.
However, multiple transfusions result in the accumulation of large quantities of iron, which
is toxic to pancreatic beta cells. Both decreased insulin production and decreased tissue
sensitivity to insulin occur and result in pre-diabetes or Type II diabetes.
Regarding the effect of exercise on diabetic patients, it is confirmed that it reduces both
the blood glucose concentration and hyperglycemia during the day. Resistance exercise
increases heat production and oxygen consumption by the muscles, thus increasing metabolic
activity and glucose uptake by these muscles. In addition, resistance exercise improves
glycemic control without causing hypoglycemia and without affecting fasting glucose. Thus,
the aim of this study is examine the effectiveness of resistance exercise in limiting
postprandial hyperglycemia in patients with beta-thalassemia and insulin resistance.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |